by V. Govindarajan, Founder and Managing Director, Aarthi Scans and Labs.
Aarthi Scans and Labs welcome the proposed GST reforms that reduce the tax rate on diagnostic kits, reagents, glucometers, and test strips from 12% to 5%. Diagnostics lies at the heart of both preventive and curative healthcare, and any initiative that lowers patient costs while enabling providers to uphold the highest standards of quality is a progressive step. By easing the tax burden on these essential tools, the reforms will make diagnostic services more affordable, encourage timely testing, and ultimately lead to earlier detection and improved health outcomes. Equally significant is the exemption of GST on health and life insurance, a move that will ease the financial burden on patients and families, promote wider adoption of insurance coverage, and ensure that healthcare is not only accessible but also sustainable in the long run. As one of the country’s leading diagnostic providers, we see these reforms as catalysts for strengthening India’s healthcare infrastructure. We remain committed to passing on these benefits to patients nationwide.